Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12882-015-0130-5
Published Online: 2015-10-16
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Koyama, Akio
Fujita, Toshiro
Gejyo, Fumitake
Origasa, Hideki
Isono, Masanao
Kurumatani, Hajimu
Okada, Kiyonobu
Kanoh, Hiroyuki
Kiriyama, Takashi
Yamada, Shunsuke
License valid from 2015-10-16